News

PI3K delta and gamma are the enzymes involved in immune cell functions, including cell proliferation, survival and cellular trafficking. The first Phase 1 trial of IPI-145 is a

Genedata Biologics advances end-to-end biologics R&D activities including antibody screening, protein engineering, and biologics production. The version 2.0 provides new protein production modules supporting production process, including molecule

Rindopepimut is an immunotherapy that targets the tumor-specific oncogene, EGFRvIII. Celldex finalized the clinical protocol for the Phase 3 randomized, double-blind study of rindopepimut in GB, after consulting

TRO40303 causes prevention of stress-induced mitochondrial permeability transition, a target implicated in cardiac reperfusion injury. The placebo-controlled, phase II proof-of-concept study in acute MI patients with large myocardial

The new software platform ensures the integrity of electronic data records that are generated under industry-standard protocols within pharma research. NexION ES has been developed for pharma lab

The assay is designed to be used on the company’s cobas e 601 analyzer, an immunoassay module of the cobas 6000 analyzerseries. The Anti-HBc IgM assay is used

In addition, the companies also entered two other influenza-related, non-exclusive license agreements and a sponsored research agreement. As per the deal, Alios will sponsor collaborative research at the

The study had been commenced in September 2011 in five European countries. Purethal Mites is a modified aluminum hydroxide-adsorbed extract of house dust mites for subcutaneous use, to

Initially, Lilly committed $70m to launch the partnership, to fight against multidrug-resistant tuberculosis (MDR-TB) and transfer technology for two Lilly medicines used to treat MDR- TB to other